United-Guardian ROE 2006-2020 | UG

Current and historical return on equity (ROE) values for United-Guardian (UG) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. United-Guardian ROE for the three months ending March 31, 2020 was 38.89%.
United-Guardian ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-03-31 $0.00B $0.01B 35.56%
2019-12-31 $0.00B $0.01B 34.78%
2019-09-30 $0.00B $0.01B 34.78%
2019-06-30 $0.00B $0.01B 34.04%
2019-03-31 $0.00B $0.01B 33.33%
2018-12-31 $0.00B $0.01B 33.33%
2018-09-30 $0.00B $0.01B 33.33%
2018-06-30 $0.00B $0.01B 32.00%
2018-03-31 $0.00B $0.01B 30.77%
2017-12-31 $0.00B $0.01B 29.09%
2017-09-30 $0.00B $0.02B 27.59%
2017-06-30 $0.00B $0.01B 27.59%
2017-03-31 $0.00B $0.02B 20.69%
2016-12-31 $0.00B $0.01B 20.69%
2016-09-30 $0.00B $0.02B 13.56%
2016-06-30 $0.00B $0.01B 13.11%
2016-03-31 $0.00B $0.02B 25.81%
2015-12-31 $0.00B $0.02B 25.40%
2015-09-30 $0.01B $0.02B 31.75%
2015-06-30 $0.00B $0.02B 26.23%
2015-03-31 $0.00B $0.02B 20.00%
2014-12-31 $0.00B $0.02B 20.00%
2014-09-30 $0.00B $0.02B 27.12%
2014-06-30 $0.01B $0.01B 33.90%
2014-03-31 $0.01B $0.02B 34.48%
2013-12-31 $0.01B $0.01B 42.86%
2013-09-30 $0.01B $0.02B 36.36%
2013-06-30 $0.01B $0.01B 35.71%
2013-03-31 $0.01B $0.01B 34.48%
2012-12-31 $0.00B $0.01B 27.12%
2012-09-30 $0.00B $0.02B 26.67%
2012-06-30 $0.00B $0.02B 27.12%
2012-03-31 $0.00B $0.02B 27.59%
2011-12-31 $0.00B $0.01B 28.07%
2011-09-30 $0.00B $0.02B 28.57%
2011-06-30 $0.00B $0.01B 29.09%
2011-03-31 $0.00B $0.01B 29.63%
2010-12-31 $0.00B $0.01B 28.07%
2010-09-30 $0.00B $0.01B 26.67%
2010-06-30 $0.00B $0.01B 25.40%
2010-03-31 $0.00B $0.02B 24.62%
2009-12-31 $0.00B $0.02B 25.00%
2009-09-30 $0.00B $0.02B 25.40%
2009-06-30 $0.00B $0.02B 26.23%
2009-03-31 $0.00B $0.02B 26.23%
2008-12-31 $0.00B $0.02B 26.67%
2008-09-30 $0.00B $0.02B 26.67%
2008-06-30 $0.00B $0.02B 26.67%
2008-03-31 $0.00B $0.02B 27.12%
2007-12-31 $0.00B $0.02B 27.59%
2007-09-30 $0.00B $0.02B 28.57%
2007-06-30 $0.00B $0.01B 29.09%
2007-03-31 $0.00B $0.01B 29.63%
2006-12-31 $0.00B $0.01B 29.63%
2006-09-30 $0.00B $0.01B 22.22%
2006-06-30 $0.00B $0.01B 22.22%
2006-03-31 $0.00B $0.01B 22.22%
2005-12-31 $0.00B $0.01B 22.22%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.072B $0.014B
UNITED GUARDIAN conducts research, product development, manufacturing and marketing of pharmaceuticals, cosmetics, health care products, medical devices, and proprietary industrial products. They also distributes a line of over 3,000 fine organic chemicals, research chemicals, test solutions, indicators, dyes and reagents.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $167.899B 29.12
Medtronic (MDT) Ireland $132.114B 21.48
Stryker (SYK) United States $73.365B 23.81
Boston Scientific (BSX) United States $53.161B 24.99
Baxter (BAX) United States $45.654B 27.87
Lonza Group Ag (LZAGY) Switzerland $36.676B 0.00
Terumo (TRUMY) Japan $29.978B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $28.400B 0.00
Zimmer Biomet Holdings (ZBH) United States $26.077B 16.41
ResMed (RMD) United States $23.266B 36.72
Smith & Nephew SNATS (SNN) United Kingdom $17.849B 0.00
Sunny Optical Technology (SNPTF) China $14.583B 0.00
Bio-Rad Laboratories (BIO) United States $14.566B 66.30
Insulet (PODD) United States $11.896B 1178.56
DiaSorin S.p.A (DSRLF) Italy $10.630B 0.00
Perrigo (PRGO) Ireland $7.466B 13.36
Quidel (QDEL) United States $7.350B 57.76
Shandong Weigao Medical Polymer (SHWGF) China $7.281B 0.00
Hill-Rom Holdings (HRC) United States $6.767B 19.08
William Demant Holdings (WILYY) Denmark $6.670B 0.00
GN STORE NORD (GNNDY) Denmark $6.590B 34.05
Canopy Growth (CGC) Canada $6.093B 0.00
Haemonetics (HAE) United States $5.517B 33.14
ICU Medical (ICUI) United States $4.158B 30.34
GW Pharmaceuticals (GWPH) United Kingdom $3.796B 0.00
Neogen (NEOG) United States $3.754B 63.59
Agios Pharmaceuticals (AGIO) United States $3.564B 0.00
Envista Holdings (NVST) United States $3.366B 0.00
NuVasive (NUVA) United States $3.106B 24.94
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.909B 0.00
National Vision Holdings (EYE) United States $2.150B 37.19
TG Therapeutics (TGTX) United States $2.055B 0.00
AtriCure (ATRC) United States $1.916B 0.00
Aurora Cannabis (ACB) Canada $1.428B 0.00
Cardiovascular Systems (CSII) United States $1.366B 0.00
NanoString Technologies (NSTG) United States $1.152B 0.00
Aphria (APHA) Canada $1.130B 0.00
Phibro Animal Health (PAHC) United States $1.060B 21.13
Cerus (CERS) United States $1.020B 0.00
MacroGenics (MGNX) United States $0.945B 0.00
InMode (INMD) Israel $0.937B 19.80
OraSure Technologies (OSUR) United States $0.902B 181.75
PetIQ (PETQ) United States $0.871B 25.15
Omeros (OMER) United States $0.811B 0.00
Quanterix (QTRX) United States $0.781B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.735B 124.46
VAREX IMAGING (VREX) United States $0.734B 18.21
Eagle Pharmaceuticals (EGRX) United States $0.701B 50.25
Meridian Bioscience (VIVO) United States $0.662B 24.94
Zynex (ZYXI) United States $0.644B 64.67
Vapotherm (VAPO) United States $0.567B 0.00
Lantheus Holdings (LNTH) United States $0.546B 10.98
LeMaitre Vascular (LMAT) United States $0.543B 30.91
Surmodics (SRDX) United States $0.503B 60.62
Owens & Minor (OMI) United States $0.500B 13.22
Repro-Med Systems (KRMD) United States $0.402B 337.33
Cytosorbents (CTSO) United States $0.370B 0.00
Utah Medical Products (UTMD) United States $0.362B 26.32
BioLife Solutions (BLFS) United States $0.336B 149.55
Viemed Healthcare (VMD) United States $0.321B 28.72
Organigram Holdings (OGI) Canada $0.306B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.283B 0.00
HEXO (HEXO) $0.258B 0.00
Female Health (VERU) United States $0.247B 0.00
InfuSystems Holdings (INFU) United States $0.233B 129.00
Chimerix (CMRX) United States $0.193B 0.00
Chembio Diagnostics (CEMI) United States $0.169B 0.00
Evolus (EOLS) United States $0.154B 0.00
Fonar (FONR) United States $0.154B 13.66
Bovie Medical (APYX) United States $0.152B 0.00
Rockwell Medical (RMTI) United States $0.148B 0.00
Exagen (XGN) United States $0.146B 0.00
Surface Oncology (SURF) United States $0.145B 0.00
United Health Products (UEEC) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) Canada $0.127B 0.00
MTech Acquisition (KERN) United States $0.123B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.109B 0.00
Brainsway (BWAY) Israel $0.084B 0.00
Wound Management Technologies (SMTI) United States $0.074B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.073B 0.00
Nephros (NEPH) United States $0.070B 0.00
Capricor Therapeutics (CAPR) United States $0.066B 0.00
GUARDION HEALTH (GHSI) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.030B 0.00
NF Energy Saving (BIMI) China $0.025B 0.00
FSD PHARMA INC (HUGE) Canada $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Myomo (MYO) United States $0.011B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00